Streetbeat News

Analyst Ratings

CAPR

Oppenheimer analyst Leland Gershell has maintained an 'Outperform' rating on Capricor Therapeutics and raised the price target from $15 to $43.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:29 pm

MGRC

Oppenheimer analyst Scott Schneeberger has reinstated an Outperform rating on McGrath RentCorp (NASDAQ:MGRC) and set a price target of $120.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:26 pm

AMD

APO

INTC

QCOM

Intel and AMD are in a competitive race against Nvidia in the semiconductor industry. Intel is facing challenges with a significant stock decline but potential investments from Apollo and acquisition talks with Qualcomm could signal a turnaround. AMD, on the other hand, has seen a stock surge due to its AI-driven growth, but recent volatility raises concerns. Intel offers a speculative high-risk, high-reward opportunity, while AMD presents a more stable investment with strong fundamentals.

Portfolio Pulse from Surbhi Jain

September 25, 2024 | 12:25 pm

CAPR

Maxim Group analyst Jason McCarthy has maintained a Buy rating on Capricor Therapeutics and raised the price target from $12 to $25.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:16 pm

CIFR

Northland Capital Markets has initiated coverage on Cipher Mining with an Outperform rating and set a price target of $6.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:11 pm

GRRR

Northland Capital Markets has maintained an 'Outperform' rating on Gorilla Tech Gr and raised its price target from $7 to $9, indicating a positive outlook for the company's stock.

Portfolio Pulse from Benzinga Newsdesk

September 25, 2024 | 12:08 pm

VALN

Analysts have mixed ratings for Valneva (NASDAQ:VALN), with a recent average price target of $25.5, slightly down from previous estimates. The company faces revenue challenges and has a high debt-to-equity ratio, but maintains a strong net margin. Analyst Edward White from HC Wainwright & Co. recently lowered his price target from $26.00 to $23.00 while maintaining a 'Buy' rating.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 12:01 pm

FL

Foot Locker (NYSE:FL) has received mixed analyst ratings over the past three months, with a recent average price target of $29.9, reflecting a 5.95% increase. Analysts have varied in their assessments, with some raising and others lowering their price targets. Foot Locker's financial metrics, such as net margin and ROE, lag behind industry averages, indicating challenges in profitability and asset utilization.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 12:01 pm

MNDY

Analysts have recently updated their ratings for Monday.Com (NASDAQ:MNDY), with a majority showing a bullish outlook. The average 12-month price target has increased by 9.91% to $291.94. The company's financial performance is strong, with significant revenue growth and a solid net margin, although its ROE is below industry averages.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 12:00 pm

AROC

In the past three months, analysts have shown a positive shift in sentiment towards Archrock (NYSE:AROC), with an increase in average price targets. The company's financial performance shows strong revenue growth and net margins, but challenges in ROE, ROA, and debt management.

Portfolio Pulse from Benzinga Insights

September 25, 2024 | 12:00 pm